Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRE-GAIN Bone Health Pilot Study
NCT04021017Phase 1Withdrawn
- Sponsor
- University of Saskatchewan
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estradiol in anorexia nervosa (AN) (2 arms), sponsored by University of Saskatchewan. Primary endpoint: Cortical Wall Thickness at 24 months. Planned start Jan 2020; status: withdrawn.
02
Drugs
estradiol
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT04021017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04021017.